1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Companion Diagnostics Market
2.2. Global Companion Diagnostics Market, By Indication, 2023 (US$ Million)
2.3. Global Companion Diagnostics Market, By Technology, 2023 (US$ Million)
2.4. Global Companion Diagnostics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Companion Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Companion Diagnostics Market Vendors
3.2. Strategies Adopted by Companion Diagnostics Market Vendors
3.3. Key Industry Strategies
4. Companion Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Companion Diagnostics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Oncology
5.3.1.1. Breast Cancer
5.3.1.2. Colorectal Cancer
5.3.1.3. Gastric Cancer
5.3.1.4. Lung Cancer
5.3.1.5. Melanoma
5.3.1.6. Others(Neurology, Prostate Cancer, and Ovarian Cancer)
5.3.2. Cardiovascular Diseases
5.3.3. Infectious Diseases
5.3.4. Autoimmune Diseases

6. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Polymerase Chain Reaction
6.3.2. Immunohistochemistry (IHC)
6.3.3. In-Situ Hybridization Test (ISH)
6.3.4. Gene Sequencing
6.3.5. Others (Monoclonal Antibodies Test and Cellular Immune Testing)


7. North America Companion Diagnostics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
7.3. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.Companion Diagnostics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
7.4.1.1.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
7.4.1.2.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
7.4.1.3.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)

8. UK and European Union Companion Diagnostics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.3. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.Companion Diagnostics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.1.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.2.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.3.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.4.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.5.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
8.4.1.6.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)

9. Asia Pacific Companion Diagnostics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.3. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.Companion Diagnostics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.1.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.2.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.3.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.4.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.5.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
9.4.1.6.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)

10. Latin America Companion Diagnostics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
10.3. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.Companion Diagnostics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
10.4.1.1.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
10.4.1.2.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
10.4.1.3.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)

11. Middle East and Africa Companion Diagnostics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
11.3. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.Companion Diagnostics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
11.4.1.1.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
11.4.1.2.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Companion Diagnostics Market: By Indication, 2022-2032, USD (Million)
11.4.1.3.2. Companion Diagnostics Market: By Technology, 2022-2032, USD (Million)

12. Company Profile
12.1. Abbott Laboratories Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. bioMerieux SA
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Qiagen N.V.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Roche Holdings AG
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Thermo Fisher Scientific
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Ventana Medical Systems
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Myriad Genetics
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Leica Microsystems
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Other Notable Players
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives